Clinical characteristics | Frozen samples (N = 108) | Paraffin samples (N = 132) | All (N = 240) |
---|---|---|---|
Age | 48.12 ± 11.47 | 53.32 ± 8.79 | 50.98 ± 10.40 |
FIGO stage | Â | Â | Â |
I–II | 23 | – | 23 |
III–IV | 85 | 132 | 217 |
Grade (serous) | Â | Â | Â |
3 | 74 | 132 | 206 |
1 | 17 | – | 17 |
Grade (mucinous and endometrioid) | Â | Â | Â |
3 | 11 | – | 11 |
2 | 1 | – | 1 |
1 | 5 | – | 5 |
Histology types | Â | Â | Â |
Serous | 91 | 132 | 223 |
Mucinous | 14 | – | 14 |
Endometrioid | 3 | – | 3 |
Surgical debulking | Â | Â | Â |
Optimal | 76 | 96 | 172 |
Suboptimal | 32 | 36 | 68 |
Chemotherapy outcome | Â | Â | Â |
Chemoresistant | 55 | 56 | 111 |
Chemosensitive | 53 | 76 | 129 |
Postoperative chemotherapy scheme | Â | Â | Â |
TP (paclitaxel plus cisplatin) | 57 | 58 | 115 |
TC (paclitaxel plus carboplatin) | 51 | 74 | 125 |